Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

267.38 -30.48 (-10.23%)
Official Closing Price Updated: 7:00 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Trump Reportedly Taps Wall Street Banks To Explore Fannie, Freddie Public Offering Strategy — Retail Eyes Fresh Highs
According to a Bloomberg News report, Trump already met JPMorgan Chase & Co. CEO Jamie Dimon last week at the White House, followed by talks with Goldman Sachs CEO David Solomon on Thursday. 
Via Stocktwits
Topics Government
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened
Via Stocktwits
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
Cigna Sees Elevated Cost Trends To Continue Into Next Year
Via Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Earnings Scheduled For July 31, 2025
 
Via Benzinga
How Is The Market Feeling About Cigna Group?
 
Via Benzinga
How Is The Market Feeling About Cigna Group?
 
Via Benzinga
Gapping S&P500 stocks in Thursday's session
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends. 
Via Chartmill
The Cigna Group (NYSE:CI) Reports Q2 Revenue Beat and Reaffirms Full-Year Outlook Despite Slight EPS Miss
Cigna Group (NYSE:CI) beat Q2 revenue estimates but slightly missed on EPS, reaffirming full-year guidance. Shares rose 4.4% pre-market as investors focused on growth. 
Via Chartmill
Cigna (NYSE:CI) Reports Strong Q2
Health insurance company Cigna (NYSE:CI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per share... 
Via StockStory
Topics Artificial Intelligence
Cigna (CI) Q2 Earnings Report Preview: What To Look For
Health insurance company Cigna (NYSE:CI) will be reporting earnings this Thursday before the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene. 
Via Benzinga
2 Profitable Stocks Worth Your Attention and 1 That Underwhelm
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Cigna Group Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
3 Value Stocks for Long-Term Investors
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Why Cigna (CI) Shares Are Sliding Today
Shares of health insurance company Cigna (NYSE:CI) fell 3.1% in the afternoon session after the major indices pulled back (Nasdaq -0.8%, S&P 500 -0.77%), largely due to escalating concerns surrounding... 
Via StockStory
Topics Artificial Intelligence Government Stocks
UnitedHealth, Centene Hit Hard By Guidance Shock, Trump's Medicaid Push
UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation. 
Via Benzinga
Topics Government
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Jim Cramer On Centene's 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: 'This Is Horrifying'
Shares of managed care provider Centene Corp. (NYSE: CNC) dropped over 40% on Wednesday, marking the worst single-day performance in the company's history. 
Via Benzinga
Amazon Wants More Power
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes. 
Via The Motley Fool
Topics Artificial Intelligence
1 S&P 500 Stock Worth Your Attention and 2 to Steer Clear Of
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
5 Insightful Analyst Questions From Cigna’s Q1 Earnings Call
Cigna’s first-quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, with management highlighting strong performance from the company’s specialty pharmacy and pharmacy... 
Via StockStory
Topics Earnings World Trade
Thursday's session: top gainers and losers in the S&P500 index
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
Senate Republicans’ Medicaid Cuts Threaten To Put Trump’s ‘Big, Beautiful Bill’ In Jeopardy Ahead Of Vote
The provisions at risk include the plan to hold down Medicaid costs by cracking down on a state provider tax. 
Via Stocktwits
Topics Government
Bristol Myers Faces Scrutiny For Allegedly Rigging Market On $2B Cancer Drug
Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse payments to delay cheaper generics of Pomalyst. 
Via Benzinga
Topics Fraud Lawsuit
Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today
 
Via Benzinga
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices. 
Via Benzinga
UnitedHealth Stock Touted For 36% Gain? JPMorgan Points To Medicare Advantage Margin Tailwind
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline. 
Via Stocktwits
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.